Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation

被引:387
作者
Schubert, M
Brazil, DP
Burks, DJ
Kushner, JA
Ye, J
Flint, CL
Farhang-Fallah, J
Dikkes, P
Warot, XM
Rio, C
Corfas, G
White, MF
机构
[1] Harvard Univ, Sch Med, Joslin Diabet Ctr, Howard Hughes Med Inst, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Dept Neurol, Div Neurosci, Boston, MA 02115 USA
关键词
diabetes; insulin receptor substrates; Irs2; growth factors; tau phosphorylation; brain size; neuron survival; Alzheimer's disease;
D O I
10.1523/JNEUROSCI.23-18-07084.2003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Insulin resistance and diabetes might promote neurodegenerative disease, but a molecular link between these disorders is unknown. Many factors are responsible for brain growth, patterning, and survival, including the insulin-insulin-like growth factor (IGF)-signaling cascades that are mediated by tyrosine phosphorylation of insulin receptor substrate (IRS) proteins. Irs2 signaling mediates peripheral insulin action and pancreatic beta-cell function, and its failure causes diabetes in mice. In this study, we reveal two important roles for Irs2 signaling in the mouse brain. First, disruption of the Irs2 gene reduced neuronal proliferation during development by 50%, which dissociated brain growth from Irs1-dependent body growth. Second, neurofibrillary tangles containing phosphorylated tau accumulated in the hippocampus of old Irs2 knock-out mice, suggesting that Irs2 signaling is neuroprotective. Thus, dysregulation of the Irs2 branch of the insulin-Igf-signaling cascade reveals a molecular link between diabetes and neurodegenerative disease.
引用
收藏
页码:7084 / 7092
页数:9
相关论文
共 88 条
[1]  
Åberg MAI, 2000, J NEUROSCI, V20, P2896
[2]   Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action [J].
Aguirre, V ;
Werner, ED ;
Giraud, J ;
Lee, YH ;
Shoelson, SE ;
White, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (02) :1531-1537
[3]   Genetic control of the mouse cerebellum: Identification of quantitative trait loci modulating size and architecture [J].
Airey, DC ;
Lu, L ;
Williams, RW .
JOURNAL OF NEUROSCIENCE, 2001, 21 (14) :5099-5109
[4]   Insulin-like growth factor-I and central nervous system development [J].
Anlar, B ;
Sullivan, KA ;
Feldman, EL .
HORMONE AND METABOLIC RESEARCH, 1999, 31 (2-3) :120-125
[5]   Exclusion of insulin receptor substrate 2 (IRS-2) as a major locus for early-onset autosomal dominant type 2 diabetes [J].
Bektas, A ;
Warram, JH ;
White, MF ;
Krolewski, AS ;
Doria, A .
DIABETES, 1999, 48 (03) :640-642
[6]   Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians [J].
Bernal, D ;
Almind, K ;
Yenush, L ;
Ayoub, M ;
Zhang, YT ;
Rosshani, L ;
Larsson, C ;
Pedersen, O ;
White, MF .
DIABETES, 1998, 47 (06) :976-979
[7]  
BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371
[8]   RhoGAP: The next big thing for small mice? [J].
Birnbaum, MJ .
DEVELOPMENTAL CELL, 2002, 2 (05) :521-523
[9]   Absence of functional insulin receptor substrate-3 (IRS-3) gene in humans [J].
Björnholm, M ;
He, AR ;
Attersand, A ;
Lake, S ;
Liu, SCH ;
Lienhard, GE ;
Taylor, S ;
Arner, P ;
Zierath, JR .
DIABETOLOGIA, 2002, 45 (12) :1697-1702
[10]   The role of the metabolic lesion in Alzheimer's disease [J].
Blass, John P. ;
Gibson, Gary E. ;
Hoyer, Siegfried .
JOURNAL OF ALZHEIMERS DISEASE, 2002, 4 (03) :225-232